SCHEMBL4097659

SCHEMBL4097659

O=C(CC1CC1)c1cccc2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.59
NR4A1 P22736 1/20 0.52
NR4A2 P43354 1/20 0.52
NR4A3 Q92570 1/20 0.52
ALDH1A1 P00352 5/20 0.51
MAPT P10636 4/20 0.51
HPGD P15428 3/20 0.51
KDM4E B2RXH2 3/20 0.51
MEN1 O00255 2/20 0.51
GMNN O75496 2/20 0.51
LMNA P02545 2/20 0.51
POLB P06746 2/20 0.51
MAPK1 P28482 2/20 0.51
BLM P54132 2/20 0.51
PMP22 Q01453 2/20 0.51
KMT2A Q03164 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
CMKLR1 Q99788 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
TP53 P04637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7382226 0.82 DRD4 (0.65) DRD4
SCHEMBL4097494 0.80 CYP1A2 (0.42) PTPN1ALDH1A1MAPTMEN1KMT2A
SCHEMBL22502969 0.79 KDM2B (0.45) PTPN1NR4A1NR4A2NR4A3ALDH1A1
SCHEMBL29457006 0.77 PTPN1 (0.71) PTPN1NR4A1NR4A2NR4A3ALDH1A1
SCHEMBL5857951 0.77 PTPN1 (0.71) PTPN1NR4A1NR4A2NR4A3ALDH1A1
SCHEMBL31591716 0.77 ALDH1A1 (0.54) PTPN1ALDH1A1MAPTHPGDKDM4E
SCHEMBL9701408 0.77 PTPN1 (0.65) PTPN1NR4A1NR4A2NR4A3ALDH1A1
SCHEMBL1448941 0.76 PTPN1 (0.69) PTPN1NR4A1NR4A2NR4A3ALDH1A1
SCHEMBL11713079 0.76 PTPN1 (0.69) PTPN1NR4A1NR4A2NR4A3ALDH1A1
SCHEMBL30375866 0.76 PTPN1 (0.69) PTPN1NR4A1NR4A2NR4A3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221645-A1 Dihydroimidazothiazole Derivatives PROSIDION LIMITED (GB) 2009-09-03 US disclosed
US-20090221645-A1 Dihydroimidazothiazole Derivatives PROSIDION LIMITED (GB) 2009-09-03 US disclosed
US-20090221645-A1 Dihydroimidazothiazole Derivatives PROSIDION LIMITED (GB) 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221645-A1 Dihydroimidazothiazole Derivatives TPH1, HTR3B, HTR1A PTPN1 2958/4885NR4A1 498/4885NR4A2 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.